Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 9.98
-0.07 (-0.70%)
Jul 14, 2026, 1:19 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 957.84 million as of July 14, 2026. Its market cap has decreased by -38.49% in one year.
Market Cap
957.84M
Enterprise Value
1.87B
Revenue
471.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.98
Market Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 957.84M, a decrease of -50.78%. That is a compound annual growth rate of -20.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 957.84M | -33.41% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
| Jun 16, 2023 | 1.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BiOptic | 1.16B |
| LabTurbo Biotech | 1.11B |
| Bio Preventive Medicine | 1.07B |
| Lukas Biomedical | 1.06B |
| Level Biotechnology | 1.04B |
| Holy Stone Healthcare | 1.03B |
| TCI GENE | 978.96M |
| U-Neuron Biomedical | 973.67M |